1. Home
  2. ATNM vs GROV Comparison

ATNM vs GROV Comparison

Compare ATNM & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.12

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

N/A

Current Price

$1.33

Market Cap

58.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
GROV
Founded
2000
2016
Country
United States
United States
Employees
N/A
415
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
58.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
GROV
Price
$1.12
$1.33
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$4.00
$1.60
AVG Volume (30 Days)
103.3K
80.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
30.60
N/A
EPS
N/A
N/A
Revenue
$81,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.02
52 Week High
$1.95
$1.69

Technical Indicators

Market Signals
Indicator
ATNM
GROV
Relative Strength Index (RSI) 45.14 38.40
Support Level $1.02 $1.19
Resistance Level $1.25 $1.35
Average True Range (ATR) 0.07 0.08
MACD 0.01 -0.02
Stochastic Oscillator 47.16 13.33

Price Performance

Historical Comparison
ATNM
GROV

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: